One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
Sumit Randhir SinghAdrian T FungSamantha Fraser-BellMarco LupidiSashwanthi MohanPierre-Henry GabrielleDinah ZurMatias IglickiPaula M López-CorellRoberto Gallego-PinazoCláudia FarinhaLuiz H LimaAhmad M MansourAntonio Marcello CasellaLihteh WuRufino SilvaSami H UwaydatVishal GovindahariJose Fernando ArevaloJay ChhablaniPublished in: The British journal of ophthalmology (2019)
Peripapillary CNVM, though uncommon, is associated with diverse aetiologies. Anti-VEGF agents lead to significant visual acuity and anatomical improvement in these eyes over long term irrespective of the aetiology.